Mycobacterium Avium Complex Lung Disease
📧 Sign up to get email alerts when something new happens for Mycobacterium Avium Complex Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease [Phase 2, Phase 3]
Phase 2/3 clinical trial results for Epetraborole in treatment-refractory MAC lung disease have been posted after termination of the study.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) [Phase 2, Phase 3]
This clinical trial update reports on a regimen including bedaquiline with clarithromycin and ethambutol for adults with treatment-refractor…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex [Phase 3]
Phase 3 trial evaluating amikacin liposome inhalation suspension (ALIS) for nontuberculous mycobacterial lung infection caused by Mycobacter…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections [Phase 3]
A Phase 3 clinical trial comparing clarithromycin versus azithromycin for treatment of Mycobacterium avium complex lung infection is current…
-
CLINICAL_TRIALS withdrawal · 2025-11-12Clinical Trial Update: ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension [Phase 3]
Phase 3 trial MNKD-101 (Clofazimine inhalation suspension) for MAC lung disease was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease [Phase 2, Phase 3]
A Phase 2/Phase 3 study of Epetraborole for treatment-refractory Mycobacterium avium complex lung disease has been terminated.
-
FDA approval · 2023-06-01FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)
The FDA approved a supplemental application for ARIKAYCE (amikacin liposome inhalation) submitted by Insmed Incorporated. This authorization…
-
FDA approval · 2020-03-13FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)
The FDA approved a supplemental application for ARIKAYCE (amikacin liposome inhalation) to expand its label for the treatment of Mycobacteri…
-
FDA approval · 2018-09-28FDA Approved: ARIKAYCE — Original Application (Insmed Incorporated)
The FDA approved ARIKAYCE (amikacin liposome inhalation suspension) from Insmed as the original approval for treatment-refractory Mycobacter…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Azithromycin in the Treatment of M. Avium Complex Lung Disease [Phase 4]
Phase 4 trial of azithromycin for Mycobacterium avium complex lung disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease [Phase 4]
A Phase 4 trial evaluating thrice-weekly azithromycin and rifabutin for Mycobacterium avium complex lung disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease [Phase 4]
Phase 4 clinical trial evaluating the combination of clarithromycin and rifabutin for Mycobacterium avium complex lung disease has completed…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Program Cell Death Receptor 1 in Mycobacterium Avium Complex Lung Disease
A completed clinical trial investigated targeting the PD-1 pathway in Mycobacterium avium complex lung disease. The study was conducted by N…
-
CLINICAL_TRIALS research · 2014-06-30Clinical Trial Update: The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung Disease
A clinical trial update examining how inflammasome activity in inflammatory versus resting macrophages responds in Mycobacterium avium compl…